Controlled release of doxorubicin from gelatin-based nanoparticles: theoretical and experimental approach
Materials Advances · 2024 · 5 (6) · 2347-2358
DOI: 10.1039/d3ma00825h ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Advances, 2024. Verfasst von Wajiha Fatima und 5 weiteren Autor:innen. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Doxorubicin (DOX), a well-known chemotherapeutic agent, is extensively used for cancer therapy.
Zitieren
APA
Fatima, W., Batool, S. R., Mushtaq, F., Aslam, M., Raza, Z. A., & Nazeer, M. A. (2024). Controlled release of doxorubicin from gelatin-based nanoparticles: theoretical and experimental approach. Materials Advances, 5(6), 2347-2358. https://doi.org/10.1039/d3ma00825h
Vancouver
Fatima W, Batool SR, Mushtaq F, Aslam M, Raza ZA, Nazeer MA. Controlled release of doxorubicin from gelatin-based nanoparticles: theoretical and experimental approach. Materials Advances. 2024;5(6):2347-2358. doi:10.1039/d3ma00825h
BibTeX
@article{Fatima2024,
author = {Fatima, Wajiha and Batool, Syeda Rubab and Mushtaq, Farwa and Aslam, Muhammad and Raza, Zulfiqar Ali and Nazeer, Muhammad Anwaar},
title = {Controlled release of doxorubicin from gelatin-based nanoparticles: theoretical and experimental approach},
journal = {Materials Advances},
year = {2024},
volume = {5},
number = {6},
pages = {2347--2358},
doi = {10.1039/d3ma00825h}
}
EUVIMED